Cubist Systematic Strategies, LLC Oramed Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.21 - $12.03 $577,387 - $1.12 Million	-92,977 Reduced 79.14%	24,500 $294,000
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $215,077 - $463,351	46,756 Added 66.11%	117,477 $761,000
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $636,756 - $1.54 Million	-171,171 Reduced 70.76%	70,721 $324,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $1.57 Million - $2.66 Million	191,316 Added 378.27%	241,892 $2.09 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $656,476 - $1.5 Million	50,576 New	50,576 $722,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.